Toward an Understanding of Disengagement from HIV Treatment and Care in Sub-Saharan Africa: A Qualitative Study
Background:
The rollout of antiretroviral therapy in sub-Saharan Africa has brought lifesaving treatment to millions of HIV-infected individuals. Treatment is lifelong, however, and to continue to benefit, patients must remain in care. Despite this, systematic investigations of retention have repeatedly documented high rates of loss to follow-up from HIV treatment programs. This paper introduces an explanation for missed clinic visits and subsequent disengagement among patients enrolled in HIV treatment and care programs in Africa.
Methods and Findings:
Eight-hundred-ninety patients enrolled in HIV treatment programs in Jos, Nigeria; Dar es Salaam, Tanzania; and Mbarara, Uganda who had extended absences from care were tracked for qualitative research interviews. Two-hundred-eighty-seven were located, and 91 took part in the study. Interview data were inductively analyzed to identify reasons for missed visits and to assemble them into a broader explanation of how missed visits may develop into disengagement. Findings reveal unintentional and intentional reasons for missing, along with reluctance to return to care following an absence. Disengagement is interpreted as a process through which missed visits and ensuing reluctance to return over time erode patients' subjective sense of connectedness to care.
Conclusions:
Missed visits are inevitable over a lifelong course of HIV care. Efforts to prevent missed clinic visits combined with moves to minimize barriers to re-entry into care are more likely than either approach alone to keep missed visits from turning into long-term disengagement.
Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Toward an Understanding of Disengagement from HIV Treatment and Care in Sub-Saharan Africa: A Qualitative Study. PLoS Med 10(1): e32767. doi:10.1371/journal.pmed.1001369
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001369
Souhrn
Background:
The rollout of antiretroviral therapy in sub-Saharan Africa has brought lifesaving treatment to millions of HIV-infected individuals. Treatment is lifelong, however, and to continue to benefit, patients must remain in care. Despite this, systematic investigations of retention have repeatedly documented high rates of loss to follow-up from HIV treatment programs. This paper introduces an explanation for missed clinic visits and subsequent disengagement among patients enrolled in HIV treatment and care programs in Africa.
Methods and Findings:
Eight-hundred-ninety patients enrolled in HIV treatment programs in Jos, Nigeria; Dar es Salaam, Tanzania; and Mbarara, Uganda who had extended absences from care were tracked for qualitative research interviews. Two-hundred-eighty-seven were located, and 91 took part in the study. Interview data were inductively analyzed to identify reasons for missed visits and to assemble them into a broader explanation of how missed visits may develop into disengagement. Findings reveal unintentional and intentional reasons for missing, along with reluctance to return to care following an absence. Disengagement is interpreted as a process through which missed visits and ensuing reluctance to return over time erode patients' subjective sense of connectedness to care.
Conclusions:
Missed visits are inevitable over a lifelong course of HIV care. Efforts to prevent missed clinic visits combined with moves to minimize barriers to re-entry into care are more likely than either approach alone to keep missed visits from turning into long-term disengagement.
Please see later in the article for the Editors' Summary
Zdroje
1. RosenS, FoxMP, GillCJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4: e298 doi:10.1371/journal.pmed.0040298.
2. FoxMP, RosenS (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health 15 (Suppl 1) 1–15.
3. CornellM, GrimsrudA, FairallL, FoxMP, van CutsemG, et al. (2010) Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007. AIDS 24: 2263–2270.
4. TassieJM, BaijalP, VitoriaMA, AlisaladA, CrowleySP, et al. (2010) Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countries. J Acquir Immune Defic Syndr 54: 437–441.
5. KooleO, KalengaL, KiumbuM, MentenJ, RyderRW, et al. (2012) Retention in an NGO supported antiretroviral program in the Democratic Republic of Congo. PLoS ONE 7: e40971 doi:10.1371/journal.pone.0040971.
6. BrinkhofMW, Pujades-RodriguezM, EggerM (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE 4: e5790 doi:10.1371/journal.pone.0005790.
7. GengEH, NashD, KambuguA, ZhangY, BraitsteinP, et al. (2010) Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep 7: 234–244.
8. GengEH, GliddenDV, BwanaMB, MusinguziN, EmenyonuN, et al. (2011) Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach. PLoS ONE 6: e21797 doi:10.1371/journal.pone.0021797.
9. MukherjeeJS, IversL, LeandreF, FarmerP, BehforouzH, et al. (2006) Antiretroviral therapy in resource-poor settings: decreasing barriers to access and promoting adherence. J Acquir Immune Defic Syndr 43 (Suppl 1) S123–S126.
10. Meyer-RuthG, RichterM (2007) User fees, transport costs, and the ethics of exemption: how free is free ART? South Afr J HIV Med 27: 52–56, 52-54, 56.
11. HardonAP, AkurutD, ComoroC, EkezieC, IrundeHF, et al. (2007) Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 19: 658–665.
12. RosenS, KetlhapileM, SanneI, DeSilvaMB (2007) Cost to patients of obtaining treatment for HIV/AIDS in South Africa. S Afr Med J 97: 524–529.
13. TullerDM, BangsbergDR, SenkunguJ, WareNC, EmenyonuN, et al. (2010) Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav 14: 778–784.
14. Hardon A, Davey S, Gerrits T, Hodgkin C, Irunde H, et al.. (2006) From access to adherence: the challenges of antiretroviral treatment. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/publications/2006/9241563281_eng.pdf. Accessed 4 December 2012.
15. WattMH, MamanS, EarpJA, EngE, SetelPW, et al. (2009) “It's all the time in my mind”: facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Soc Sci Med 68: 1793–1800.
16. GilbertL, WalkerL (2009) “They (ARVs) are my life, without them I'm nothing”—experiences of patients attending a HIV/AIDS clinic in Johannesburg, South Africa. Health Place 15: 1123–1129.
17. LarsonBA, BrennanA, McNamaraL, LongW, RosenS, et al. (2010) Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health 15 (Suppl 1) 43–47.
18. MulissaA, JereneD, BindtjornB (2010) Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. PLoS ONE 5: e13268 doi:10.1371/journal.pone.0013268.
19. ClouseK, PettiforAE, MaskewM, BassettJ, Van RieA, et al. (2012) Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary healthcare clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr E-pub ahead of print. doi:10.1097/QAI.0b013e318273ac48.
20. AmuronB, NamaraG, BirungiJ, NabiryoC, LevinJ, et al. (2009) Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9: 290.
21. BassettIV, WangB, ChettyS, MazibuckoM, BearnotB, et al. (2009) Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr 51: 135–139.
22. Taylor-SmithK, ZachariahR, MassaquoiM, ManziM, PasulaniO, et al. (2010) Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system? Trans R Soc Trop Med Hyg 104: 313–319.
23. LessellsRU, MutevedziPC, CookeGS, NewellML (2011) Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr 56: e79 doi:10.1097/QAI.0b013e3182075ae2.
24. MassaquoiM, ZachariahR, ManziM, PasulaniO, MisindiD, et al. (2009) Patient retention and attrition on antiretroviral treatment at district level in rural Malawi. Trans R Soc Trop Med Hyg 103: 594–600.
25. ChanAK, MateyuG, JahnA, SchoutenE, AroraP, et al. (2010) Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model. Trop Med Int Health 15: 90–97.
26. O'ConnorC, OsihR, JafferA (2011) Loss to follow-up of stable antiretroviral therapy patients in a decentralized down referral model of care in Johannesburg, South Africa. J Acquir Immune Defic Syndr 58: 429–432.
27. BedeluM, FordN, HilderbrandK, ReuterH (2007) Implementing antiretroviral therapy in rural communities: the Lusikisiki Model of decentralized HIV/AIDS care. J Infect Dis 196 (Suppl 3) S464–S468.
28. CharuratM, OyegunleM, BenjaminR, HabibA, EzeE, et al. (2010) Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS ONE 5: e10584 doi:10.1371/journal.pone.0010584.
29. WangB, LosinaE, StarkR, MunroA, WalenskyRP, et al. (2011) Loss to follow-up in a community clinic in South Africa—roles of gender, pregnancy and CD4 count. S Afr Med J 101: 253–257.
30. WeigelR, EstillJ, EggerM, HarriesAD, MakombeS, et al. (2012) Mortality and loss to follow-up in the first year of ART: Malawi national ART programme. AIDS 26: 365–373.
31. BoylesTH, WilkinsonLS, LeisegangR, MaartensG (2011) Factors influencing retention in care after starting antiretroviral therapy in a rural South African setting. PLoS ONE 6: e19201 doi:10.1371/journal.pone.0019201.
32. Ochieng-OokoV, OchiengD, SidleJE, HoldsworthM (2010) Influence of gender on loss to follow-up in a large HIV treatment program in western Kenya. Bull World Health Organ 88: 681–688 doi:10.2471/BLT.09.064329.
33. MaskewM, MacPhailP, MenezesC, RubelD (2009) Loss to follow up—contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J 97: 853–857.
34. MillerCM, KetlhapileM, Rybasack-SmithH, RosenS (2010) Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health 15 (Suppl 1) 48–54.
35. RouraM, BuszaJ, WringeA, MbataD, UrassaM, et al. (2009) Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: a follow-up study to understand attrition from the antiretroviral program. AIDS Patient Care STDS 23: 203–210.
36. KrebsDW, ChiBH, MulengaY, MorrisM, CantrellRA, et al. (2008) Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care 20: 311–317.
37. McGuireM, MunyenyembeT, SzumilinE, HeinzelmannA, PaihML, et al. (2010) Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health 15 (Suppl 1) 55–62.
38. RosenS, KetlhapileM (2010) Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa. Trop Med Int Hlth 15 (Suppl 1) 98–104.
39. AlamoST, ColebundersR, OumaJ, SundayP, WagnerG, et al. (2012) Return to normal life after AIDS as a reason for loss to follow-up in a community-based antiretroviral treatment program. J Acquir Immune Defic Syndr 60: e36–e45.
40. MertenS, KenterE, McKenzieO, MushekeM, NtalashaH, et al. (2010) Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography. Trop Med Int Health 15 (Suppl 1) 16–33.
41. WringeA, RouraM, UrassaM, BuszaJ, AthanasV, et al. (2009) Doubts, denial and divine intervention: understanding delayed attendance and poor retention rates at a HIV treatment programme in rural Tanzania. AIDS Care 21: 632–637.
42. WareNC, IdokoJ, KaayaS, BiraroIA, WyattMA, et al. (2009) Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med 6: e11 doi:10.1371/journal.pmed.1000011.
43. AVERTing HIV and AIDS (2012) The HIV and AIDS epidemic in Africa. Available: http://www.avert.org/aids-hiv-africa.htm. Accessed 4 December 2012.
44. The World Bank (2012) Nigeria maps AIDS epidemic, future of HIV fight. Available: http://go.worldbank.org/2T6K8LIYF0. Accessed 4 December 2012.
45. Glaser BC, Strauss AL (1967) The discovery of grounded theory: strategies for qualitative research. New York: Aldiric de Gruyter. 271 p.
46. Corbin J, Strauss A (2008) Basics of qualitative research. Los Angeles: Sage Publications. 379 p.
47. JewkesR, AbrahamsN, MvoZ (1998) Why do nurses abuse patients? Reflections from South African obstetric services. Soc Sci Med 47: 1781–1795.
48. EadesCA, BraceC, OseiL, LaGuardiaKD (1993) Traditional birth attendants and maternal mortality in Ghana. Soc Sci Med 36: 1503–1507.
49. GilsonM, AlilioM, HeggenhougenK (1994) Community satisfaction with primary health care services: an evaluation undertaken in the Morogoro region of Tanzania. Soc Sci Med 39: 767–780.
50. Abdool KarimQ, Preston-WhyteE, Abdool KarimSS (1992) Teenagers seeking condoms at family planning services. Part 1: a user's perspective. S Afr Med J 82: 356–359.
51. CampbellC, ScottK, MadanhireC, NyamukapaC, GregsonS (2011) A ‘good hospital’: nurse and patient perceptions of good clinical care for HIV-positive people on antiretroviral treatment in rural Zimbabwe—a mixed-methods qualitative study. Int J Nurs Stud 48: 175–183.
52. ManongiRN, NasuwaFR, MwangiR, ReyburnH, PoulsenA, et al. (2009) Conflicting priorities: evaluation of an intervention to improve nurse-parent relationships on a Tanzanian paediatric ward. Hum Resour Health 7: 50 doi:10.1186/1478-4491-7-50.
53. Bowser D, Hill K (2010) Exploring evidence for disrespect and abuse in facility-based childbirth: report of a landscape analysis. Bethesda (Maryland): USAID-TRAction Project.
54. YakongVN, RushKL, Bassett-SmithJ, BottorffJL, RobinsonC (2010) Women's experiences of seeking reproductive health care in rural Ghana: challenges for maternal health service utilization. J Adv Nurs 66: 2431–2441.
55. SomeTD, SombieI, MedaN (2011) Women's perceptions of homebirths in two rural medical districts in Burkina Faso: a qualitative study. Reprod Health 8: 3 doi:10.1186/1742-4755-8-3.
56. SirilH, HirschhornLR, HawkinsC, GarciaME, LiMS, et al. (2011) Stress, motivation and professional satisfaction among health care workers in HIV/AIDS care and treatment centers in urban Tanzania: a cross-sectional study. East Afr J Public Health 8: 17–24.
57. SteinJ, LewinS, FairallL (2007) Hope is the pillar of the universe: health-care providers' experiences of delivering antiretroviral therapy in primary health care clinics in the Free State of South Africa. Soc Sci Med 64: 965–964.
58. HarriesAD, ZachariahR, LawnSD, RosenS (2010) Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health (Suppl 1) 70–75.
59. RichML, MillerAC, NiyigenaP, FrankeMF, NiyonzimaJB, et al. (2012) Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda. J Acquir Immune Defic Syndr 59: e35–e42.
60. AchiengL, MusangiH, Ong'utiS, OmbegohE, BryantL, et al. (2102) An observational cohort comparison of facilitators of retention in care and adherence to antiretroviral therapy at an HIV treatment center in Kenya. PLoS ONE 7: e32727 doi:10.1371/journal.pone.0032727.
61. TweyaH, GaretaD, ChagweraF, Ben-SmithA, MwenyemasiJ, et al. (2010) Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the ‘Back-to-Care’ project in Lilongwe, Malawi. Trop Med Int Health 15 (Suppl 1) 82–89.
62. WeigelR, HochgesangM, BrinkhofMWG, HosseinipourMC, BoxshallM, et al. (2011) Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi. BMC Infect Dis 11: 31 doi:10.1186/1471-2334-11-31.
63. World Health Organization (2012) Nigeria: health profile. Available: http://www.who.int/gho/countries/nga.pdf. Accessed 4 December 2012.
64. World Health Organization (2012) Uganda: health profile. Available: http://www.who.int/gho/countries/uga.pdf. Accessed 4 December 2012.
65. World Health Organization (2012) United Republic of Tanzania: health profile. Available: http://www.who.int/gho/countries/tza.pdf. Accessed 4 December 2012.
66. Nasidi A, Harry TO (2006) The epidemiology of HIV/AIDS in Nigeria. In: Adeyi O, Kanki PJ, Odutolu O, Idoko JA, editors. AIDS in Nigeria: a nation on the threshold. Cambridge (Massachusetts): Harvard Center for Population and Development Studies.
67. Uganda AIDS Commission Secretariat (2002) HIV/AIDS in Uganda: the epidemic and the response. Available: http://www.aidsuganda.org/documents/hiv_aids_impact.pdf. Accessed 4 December 2012.
68. Garbus L (2004) HIV/AIDS in Tanzania. San Francisco (California): University of California San Francisco AIDS Policy Research Center. Available: http://ari.ucsf.edu/programs/policy/countries/Tanzania.pdf. Accessed 4 December 2012.
69. Reuters New Media (2006 March 14) Nigeria opens 41 new AIDS treatment centres. Available: http://www.aegis.org/DisplayContent/?SectionID=65818. Accessed 4 December 2012.
70. WasswaH (2008) More than half of Ugandan AIDS patients don't get the drugs they need. BMJ 336: 348–349 doi:10.1136/bmj.39486.598044.
71. World Health Organization (2005) United Republic of Tanzania: summary country profile for HIV/AIDS treatment scale-up. Available: http://www.who.int/hiv/HIVCP_TZA.pdf. Accessed 4 December 2012.
72. Joint United Nations Programme on HIV/AIDS (2012) Regions and countries: Nigeria. Available: http://www.unaids.org/en/regionscountries/countries/nigeria/. Accessed 4 December 2012.
73. Joint United Nations Programme on HIV/AIDS (2012) Regions and countries: Uganda. Available: http://www.unaids.org/en/regionscountries/countries/uganda/. Accessed 4 December 2012.
74. Joint United Nations Programme on HIV/AIDS (2012) Regions and countries: United Republic of Tanzania. Available: http://www.unaids.org/en/regionscountries/countries/unitedrepublicoftanzania/. Accessed 4 December 2012.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 1
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Differences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin
- The Effectiveness of Mobile-Health Technologies to Improve Health Care Service Delivery Processes: A Systematic Review and Meta-Analysis
- The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
- Why Do Women Not Use Antenatal Services in Low- and Middle-Income Countries? A Meta-Synthesis of Qualitative Studies